Exploitation of the biologic activity of neurotrophins is desirable for medical purposes, but their protein nature intrinsically bears adverse pharmacokinetic properties. Here, we report synthesis and biologic characterization of a novel class of low molecular weight, non-peptidic compounds with NGF-mimetic properties. MT2, a representative compound , bound to TrkA chain on NGF-sensitive cells, as well as in cell-free assays, at nanomolar concentrations and induced TrkA autophosphorylation and receptor-mediated internalization. MT2 binding involved at least two aminoacid residues within TrkA molecule. Like NGF, MT2 increased phosphorylation of ERK1/2 and Akt proteins and production of MKP-1 phosphatase, modulated p38 MAPK activation, sustained survival of serum-starved PC12 or RDG cells and promoted their differentiation. However, the intensity of such responses was heterogenous, since the ability of maintaining survival was equally possessed by NGF and MT2, whereas induction of differentiation was expressed at definitely lower levels by the mimetic. Analysis of TrkA autophosphorylation patterns induced by MT2 revealed a strong Tyr490 and a limited Tyr785 and Tyr674/675 activation, findings coherent with the observed functional divarication. Consistently, in an NGF-deprived rat hippocampal neuronal model of Alzheimer Disease, MT2 could correct the biochemical abnormalities and sustain cell survival. Thus, NGF mimetics may reveal interesting investigational tools in neurobiology as well as promising drug candidates.

Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity / D. Scarpi; D. Cirelli; C. Matrone; G. Castronovo; P. Rosini; E. G. Occhiato; F. Romano; L. Bartali; A. M. Clemente; G. Bottegoni; A. Cavalli; G. De Chiara; P. Bonini; P. Calissano; A. T. Palamara; E. Garaci; M. G. Torcia; A. Guarna; F. Cozzolino. - In: CELL DEATH & DISEASE. - ISSN 2041-4889. - ELETTRONICO. - 3:(2012), pp. 0-0. [10.1038/cddis.2012.80]

Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity

SCARPI, DINA;CIRELLI, DOMENICO;CASTRONOVO, GIUSEPPE;ROSINI, PAOLO;OCCHIATO, ERNESTO GIOVANNI;ROMANO, FRANCESCA;BARTALI, LAURA;CLEMENTE, ANN MARIA;BONINI, PAOLO;TORCIA, MARIA;GUARNA, ANTONIO;COZZOLINO, FEDERICO
2012

Abstract

Exploitation of the biologic activity of neurotrophins is desirable for medical purposes, but their protein nature intrinsically bears adverse pharmacokinetic properties. Here, we report synthesis and biologic characterization of a novel class of low molecular weight, non-peptidic compounds with NGF-mimetic properties. MT2, a representative compound , bound to TrkA chain on NGF-sensitive cells, as well as in cell-free assays, at nanomolar concentrations and induced TrkA autophosphorylation and receptor-mediated internalization. MT2 binding involved at least two aminoacid residues within TrkA molecule. Like NGF, MT2 increased phosphorylation of ERK1/2 and Akt proteins and production of MKP-1 phosphatase, modulated p38 MAPK activation, sustained survival of serum-starved PC12 or RDG cells and promoted their differentiation. However, the intensity of such responses was heterogenous, since the ability of maintaining survival was equally possessed by NGF and MT2, whereas induction of differentiation was expressed at definitely lower levels by the mimetic. Analysis of TrkA autophosphorylation patterns induced by MT2 revealed a strong Tyr490 and a limited Tyr785 and Tyr674/675 activation, findings coherent with the observed functional divarication. Consistently, in an NGF-deprived rat hippocampal neuronal model of Alzheimer Disease, MT2 could correct the biochemical abnormalities and sustain cell survival. Thus, NGF mimetics may reveal interesting investigational tools in neurobiology as well as promising drug candidates.
2012
3
0
0
D. Scarpi; D. Cirelli; C. Matrone; G. Castronovo; P. Rosini; E. G. Occhiato; F. Romano; L. Bartali; A. M. Clemente; G. Bottegoni; A. Cavalli; G. De Chiara; P. Bonini; P. Calissano; A. T. Palamara; E. Garaci; M. G. Torcia; A. Guarna; F. Cozzolino
File in questo prodotto:
File Dimensione Formato  
cddis201280a-1.pdf

Accesso chiuso

Descrizione: CDDIS
Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 962.6 kB
Formato Adobe PDF
962.6 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/628710
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 49
  • ???jsp.display-item.citation.isi??? 39
social impact